Save time and get answers to complex questions with AI chat
The expiration date of the key patent for guselkumab?When is the expected fda decision date for apotex's ruxolitinib resubmission?Symbravo ingredients mechanism of action?Chlorpheniramine cost?Mebendazole ingredients?
See the DrugPatentWatch profile for Otrexup
When does Otrexup patent protection end? The primary patents for Otrexup are set to expire in 2029 [1]. However, the exact date for the end of market exclusivity can be influenced by various factors, including potential patent challenges and the approval of generic alternatives. What is Otrexup used for? Otrexup is a once-weekly injectable prescription medication used to treat children and adults with severe, active rheumatoid arthritis (RA) that has not responded well to other treatments [1]. It is also used to manage symptoms of polyarticular juvenile idiopathic arthritis (pJIA) in children aged two and older [1]. How does Otrexup work? Otrexup is a disease-modifying antirheumatic drug (DMARD) containing methotrexate [1]. Methotrexate works by reducing the activity of the immune system, which helps to slow down the progression of rheumatoid arthritis and juvenile idiopathic arthritis [1]. What are the potential side effects of Otrexup? Common side effects associated with Otrexup include mouth sores, nausea, stomach upset, diarrhea, and temporary hair loss [1]. More serious side effects can occur, such as liver damage, lung problems, kidney damage, and a weakened immune system, making patients more susceptible to infections [1]. It is crucial for patients to discuss any concerns about side effects with their healthcare provider [1]. Are there lower-cost alternatives to Otrexup? The cost of Otrexup can vary, and patients seeking more affordable options may explore several avenues. Generic versions of methotrexate injections exist and are typically less expensive than brand-name medications like Otrexup [2]. For Otrexup specifically, the availability of generic alternatives will depend on patent expirations and regulatory approvals. DrugPatentWatch.com tracks patent information and potential generic entry dates for many drugs, including Otrexup [1]. Consulting with a healthcare provider or pharmacist can also help identify suitable and cost-effective treatment options, including other DMARDs or different formulations of methotrexate [1]. Sources: [1] DrugPatentWatch.com [2] https://www.drugpatentwatch.com/
Other Questions About Otrexup :